Literature DB >> 25595793

Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection.

Chenglong Sun1, Stefan A Schattgen2, Prapaporn Pisitkun3, Joan P Jorgensen1, Adam T Hilterbrand4, Lucas J Wang4, John A West5, Kathrine Hansen1, Kristy A Horan6, Martin R Jakobsen1, Peter O'Hare7, Heiko Adler8, Ren Sun9, Hidde L Ploegh10, Blossom Damania5, Jason W Upton4, Katherine A Fitzgerald2, Søren R Paludan11.   

Abstract

Herpesviruses are DNA viruses harboring the capacity to establish lifelong latent-recurrent infections. There is limited knowledge about viruses targeting the innate DNA-sensing pathway, as well as how the innate system impacts on the latent reservoir of herpesvirus infections. In this article, we report that murine gammaherpesvirus 68 (MHV68), in contrast to α- and β-herpesviruses, induces very limited innate immune responses through DNA-stimulated pathways, which correspondingly played only a minor role in the control of MHV68 infections in vivo. Similarly, Kaposi's sarcoma-associated herpesvirus also did not stimulate immune signaling through the DNA-sensing pathways. Interestingly, an MHV68 mutant lacking deubiquitinase (DUB) activity, embedded within the large tegument protein open reading frame (ORF)64, gained the capacity to stimulate the DNA-activated stimulator of IFN genes (STING) pathway. We found that ORF64 targeted a step in the DNA-activated pathways upstream of the bifurcation into the STING and absent in melanoma 2 pathways, and lack of the ORF64 DUB was associated with impaired delivery of viral DNA to the nucleus, which, instead, localized to the cytoplasm. Correspondingly, the ORF64 DUB active site mutant virus exhibited impaired ability to establish latent infection in wild-type, but not STING-deficient, mice. Thus, gammaherpesviruses evade immune activation by the cytosolic DNA-sensing pathway, which, in the MHV68 model, facilitates establishment of infections.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25595793      PMCID: PMC4323864          DOI: 10.4049/jimmunol.1402495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response.

Authors:  Seungmin Hwang; Kyeong Seon Kim; Emilio Flano; Ting-Ting Wu; Leming M Tong; Ann N Park; Moon Jung Song; David Jesse Sanchez; Ryan M O'Connell; Genhong Cheng; Ren Sun
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

2.  Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.

Authors:  E J Usherwood; J P Stewart; K Robertson; D J Allen; A A Nash
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

3.  Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.

Authors:  Alec J Redwood; Martin Messerle; Nicole L Harvey; Christopher M Hardy; Ulrich H Koszinowski; Malcolm A Lawson; Geoffrey R Shellam
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae.

Authors:  Lisa M Kattenhorn; Gregory A Korbel; Benedikt M Kessler; Eric Spooner; Hidde L Ploegh
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

5.  TLR9 contributes to antiviral immunity during gammaherpesvirus infection.

Authors:  Simone Guggemoos; Doris Hangel; Svetlana Hamm; Antje Heit; Stefan Bauer; Heiko Adler
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

6.  Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.

Authors:  Koichi Tabeta; Philippe Georgel; Edith Janssen; Xin Du; Kasper Hoebe; Karine Crozat; Suzanne Mudd; Louis Shamel; Sosathya Sovath; Jason Goode; Lena Alexopoulou; Richard A Flavell; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

7.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.

Authors:  Akinori Takaoka; Zhichao Wang; Myoung Kwon Choi; Hideyuki Yanai; Hideo Negishi; Tatsuma Ban; Yan Lu; Makoto Miyagishi; Tatsuhiko Kodama; Kenya Honda; Yusuke Ohba; Tadatsugu Taniguchi
Journal:  Nature       Date:  2007-07-08       Impact factor: 49.962

8.  Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1.

Authors:  Dustin Verpooten; Yijie Ma; Songwang Hou; Zhipeng Yan; Bin He
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

9.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC.

Authors:  Veit Hornung; Andrea Ablasser; Marie Charrel-Dennis; Franz Bauernfeind; Gabor Horvath; Daniel R Caffrey; Eicke Latz; Katherine A Fitzgerald
Journal:  Nature       Date:  2009-01-21       Impact factor: 49.962

Review 10.  Viral evasion and subversion of pattern-recognition receptor signalling.

Authors:  Andrew G Bowie; Leonie Unterholzner
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

View more
  53 in total

Review 1.  Animal models of tumorigenic herpesviruses--an update.

Authors:  Dirk P Dittmer; Blossom Damania; Sang-Hoon Sin
Journal:  Curr Opin Virol       Date:  2015-10       Impact factor: 7.090

2.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

Review 3.  A proteomics perspective on viral DNA sensors in host defense and viral immune evasion mechanisms.

Authors:  Marni S Crow; Aaron Javitt; Ileana M Cristea
Journal:  J Mol Biol       Date:  2015-02-26       Impact factor: 5.469

4.  In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.

Authors:  Yuki Nakaya; Spyridon Stavrou; Kristin Blouch; Peter Tattersall; Susan R Ross
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 5.  Activation and regulation of DNA-driven immune responses.

Authors:  Søren R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2015-06       Impact factor: 11.056

Review 6.  Innate Sensing of DNA Virus Genomes.

Authors:  Zhe Ma; Guoxin Ni; Blossom Damania
Journal:  Annu Rev Virol       Date:  2018-09-29       Impact factor: 10.431

7.  Murine Gammaherpesvirus 68 Pathogenesis Is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production upon Extrinsic Stimulation in Culture.

Authors:  Brandon Cieniewicz; Qiwen Dong; Gang Li; James C Forrest; Bryan C Mounce; Vera L Tarakanova; Adrianus van der Velden; Laurie T Krug
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 8.  Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1.

Authors:  Chunfu Zheng
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

9.  A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.

Authors:  Brock G Bennion; Harshad Ingle; Teresa L Ai; Cathrine A Miner; Derek J Platt; Amber M Smith; Megan T Baldridge; Jonathan J Miner
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

10.  HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression.

Authors:  Maria H Christensen; Søren B Jensen; Juho J Miettinen; Stefanie Luecke; Thaneas Prabakaran; Line S Reinert; Thomas Mettenleiter; Zhijian J Chen; David M Knipe; Rozanne M Sandri-Goldin; Lynn W Enquist; Rune Hartmann; Trine H Mogensen; Stephen A Rice; Tuula A Nyman; Sampsa Matikainen; Søren R Paludan
Journal:  EMBO J       Date:  2016-05-27       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.